Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: FMR LLC May 6, 2026 11:07AM
Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: FMR LLC Feb 12, 2025 09:28AM
Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC Nov 12, 2024 09:56AM
Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC Feb 9, 2024 08:51AM
Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC Feb 9, 2023 10:02AM


Feb 9, 2022 09:16AM Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC
Oct 12, 2021 09:26AM Form SC 13G Celldex Therapeutics, Filed by: FMR LLC
May 10, 2018 10:51AM Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC
Feb 13, 2018 09:42AM Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC
Dec 11, 2017 10:39AM Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC
May 10, 2017 09:52AM Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC
Feb 14, 2017 10:57AM Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC
Feb 12, 2016 09:04AM Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC
Feb 13, 2015 10:07AM Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC
Sep 10, 2013 10:01AM FMR LLC Raises Stake in Celldex Therapeutics (CLDX) to 10.21%